The Harvard research funding crisis has prompted significant alarm among researchers at the prestigious university, particularly at the Wyss Institute, where Don Ingber leads innovative projects aimed at revolutionizing medicine.Following the abrupt stoppage of around $2.2 billion in government research funding, many initiatives, including Ingber’s groundbreaking organ-on-a-chip technology, are at risk.